In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL

Table 1

Baseline characteristics of the subjects.

	Control	Crohn’s disease active	Crohn’s disease remission	Sepsis
Age,  years	28 (3)	43 (10)	48 (15)	65 (12)^∗
Male/female	3/2	5/0	4/1	5/3
TC,  mmol/L	4.7 (0.6)	4.0 (0.6)	5.12 (1.6)	1.9 (1.0)^∗∗
LDLc,  mmol/L	2.57 (0.6)	2.14 (0.4)	3.06 (1.4)	1.27 (0.6)^∗∗
TG,  mmol/L	1.03 (0.5)	1.25 (1.2)	1.22 (0.7)	1.70 (0.7)
CRP,  mg/L	0.5 (0.2)	23.5 (27.8)	2.2 (1.8)	282 (109)^∗∗

Data are presented as mean (±SD). TC: total cholesterol; LDLc: low density lipoprotein cholesterol; HDLc: high-density lipoprotein cholesterol; TG: triglycerides; apo: apolipoprotein. ^∗𝑃<0.05; ^∗∗𝑃<0.01 versus controls.